Literature DB >> 17079444

Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma.

Michael H Muders1, Shamit K Dutta, Ling Wang, Julie S Lau, Resham Bhattacharya, Thomas C Smyrk, Suresh T Chari, Kaustubh Datta, Debabrata Mukhopadhyay.   

Abstract

Regulator of G-protein signaling-GAIP-interacting protein COOH terminus (GIPC) is involved in protein trafficking, endocytosis, and receptor clustering and is associated with insulin-like growth factor I receptor (IGF-IR), a receptor important for proliferation and anchorage-independent growth. Here, we described GIPC expression in different human pancreatic adenocarcinoma (PCA) cell lines and we examined the role of GIPC in the regulation of IGF-IR protein levels in PCA. Interestingly, inhibition of GIPC expression by RNA interference led to reduced IGF-IR protein levels and a subsequent decrease in proliferation of PCA cells. We also determined that the PDZ domain of GIPC is essential for the post-translational regulation and the binding of IGF-IR. The importance of GIPC in pancreatic cancer development and progression is supported by tissue microarray data of 300 pancreatic cancer specimens where GIPC is highly expressed in PCA. Taken together, our data suggest that GIPC is a central molecule for the stability of IGF-IR and could be a target for future therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079444     DOI: 10.1158/0008-5472.CAN-06-2321

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  RGS-GAIP-interacting protein controls breast cancer progression.

Authors:  Ling Wang; Julie S Lau; Chitta Ranjan Patra; Ying Cao; Santanu Bhattacharya; Shamit Dutta; Debashis Nandy; Enfeng Wang; Chamila N Rupasinghe; Pawan Vohra; Mark R Spaller; Debabrata Mukhopadhyay
Journal:  Mol Cancer Res       Date:  2010-10-27       Impact factor: 5.852

Review 2.  Minireview: Role of intracellular scaffolding proteins in the regulation of endocrine G protein-coupled receptor signaling.

Authors:  Cornelia Walther; Stephen S G Ferguson
Journal:  Mol Endocrinol       Date:  2015-05-05

Review 3.  Emerging Themes in PDZ Domain Signaling: Structure, Function, and Inhibition.

Authors:  Xu Liu; Ernesto J Fuentes
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-28       Impact factor: 6.813

Review 4.  New insights into pancreatic cancer-induced paraneoplastic diabetes.

Authors:  Raghuwansh P Sah; Sajan Jiv Singh Nagpal; Debabrata Mukhopadhyay; Suresh T Chari
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

5.  Inhibition of endoglin-GIPC interaction inhibits pancreatic cancer cell growth.

Authors:  Krishnendu Pal; Alexandre A Pletnev; Shamit K Dutta; Enfeng Wang; Ruizhi Zhao; Aradhita Baral; Vinod Kumar Yadav; Suruchi Aggarwal; Soundararajan Krishnaswamy; Khalid M Alkharfy; Shantanu Chowdhury; Mark R Spaller; Debabrata Mukhopadhyay
Journal:  Mol Cancer Ther       Date:  2014-08-14       Impact factor: 6.261

6.  Neuropilin-1 (NRP-1)/GIPC1 pathway mediates glioma progression.

Authors:  Guilong Zhang; Lukui Chen; Kouhong Sun; Ahsan Ali Khan; Jianghua Yan; Hongyi Liu; Ailin Lu; Ning Gu
Journal:  Tumour Biol       Date:  2016-08-01

7.  Chemically modified peptides targeting the PDZ domain of GIPC as a therapeutic approach for cancer.

Authors:  Chitta Ranjan Patra; Chamila N Rupasinghe; Shamit K Dutta; Santanu Bhattacharya; Enfeng Wang; Mark R Spaller; Debabrata Mukhopadhyay
Journal:  ACS Chem Biol       Date:  2012-02-15       Impact factor: 5.100

8.  Synectin-dependent regulation of arterial maturation.

Authors:  Julie M D Paye; Li-Kun Phng; Anthony A Lanahan; Holger Gerhard; Michael Simons
Journal:  Dev Dyn       Date:  2009-03       Impact factor: 3.780

9.  Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1.

Authors:  Claudia Prahst; Mélanie Héroult; Anthony A Lanahan; Noa Uziel; Ofra Kessler; Niva Shraga-Heled; Michael Simons; Gera Neufeld; Hellmut G Augustin
Journal:  J Biol Chem       Date:  2008-07-15       Impact factor: 5.157

10.  Impact of the adaptor protein GIPC1/Synectin on radioresistance and survival after irradiation of prostate cancer.

Authors:  A Singer; Y Deuse; U Koch; T Hölscher; D Pfitzmann; C Jakob; S Hehlgans; G B Baretton; A Rentsch; M Baumann; M H Muders; M Krause
Journal:  Strahlenther Onkol       Date:  2012-11-07       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.